What is Nuvation Bio's derivative assets - fair value?

Nuvation Bio (NUVB) reported derivative assets - fair value of $2.87M in Q4 2025.

How has Nuvation Bio's derivative assets - fair value changed year-over-year?

Nuvation Bio's derivative assets - fair value increased by 39.6% year-over-year, from $2.05M to $2.87M.

What is the long-term trend for Nuvation Bio's derivative assets - fair value?

Over 4 years (2021 to 2025), Nuvation Bio's derivative assets - fair value has grown at a -28.6% compound annual growth rate (CAGR), from $11.04M to $2.87M.

Nuvation Bio NUVB Derivative Assets - Fair Value

Derivative Assets - Fair Value at other companies

PfizerPFE

——

Jazz PharmaceuticalsJAZZ

——

Gilead SciencesGILD

——

Other financials

Income statement

See full

Revenue$83.2M+2,599%

Gross profit$9.8M+1,340%

Operating income$3.9M+107%

Net income$5.4M+110%

EPS (diluted)$0.01+106%

Balance sheet

See full

Cash & equivalents$125.4M+161%

Total debt$57.2M+401%

Total equity$319.6M-23.8%

Total assets$610.2M+23.9%

Cash flow

See full

Operating cash flow$5.1M+112%

CapEx$48.0K-33.3%

Free cash flow$5.0M+112%

Valuation

See full

Market cap$2.25B+150%

Profitability

See full

Gross margin54.3%+39.5pp

Operating margin-105%-52.0pp

Net margin-102.1%-50.6pp

FCF margin-93.5%-45.2pp

Returns & leverage

See full

Return on equity-39.5%-15.8pp

Debt / equity0.2×+0.2×

Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:DerivativeFairValueOfDerivativeLiability.

The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's derivative assets - fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nuvation Bio's derivative assets - fair value?: Nuvation Bio (NUVB) reported derivative assets - fair value of $2.87M in Q4 2025.
How has Nuvation Bio's derivative assets - fair value changed year-over-year?: Nuvation Bio's derivative assets - fair value increased by 39.6% year-over-year, from $2.05M to $2.87M.
What is the long-term trend for Nuvation Bio's derivative assets - fair value?: Over 4 years (2021 to 2025), Nuvation Bio's derivative assets - fair value has grown at a -28.6% compound annual growth rate (CAGR), from $11.04M to $2.87M.